Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 4/2003

01-04-2003 | Article

Usefulness of Gram Stain for Diagnosis of Lower Respiratory Tract Infection or Urinary Tract Infection and as an Aid in Guiding Treatment

Authors: E. J. Kuijper, J. van der Meer, M. D. de Jong, P. Speelman, J. Dankert

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2003

Login to get access

Abstract

During a prospective study of 8 months duration conducted in the Department of Internal Medicine and the Department of Pulmonary Diseases of the Academic Medical Centre, Amsterdam, Gram stainings of sputa and urine were performed for all patients whose clinical symptoms indicated an acute urinary tract infection or pulmonary infection. On the test request, the physician reported which antibiotic treatment he would prescribe if a microscopic examination was not available. The results of the Gram stain were discussed by the microbiologist with the physician, and the antibiotic therapy recommended by the microbiologist was recorded. This recommendation was compared with the antibiotic prescription noted in the patient record 1 day later. Two days after the results of final cultures and susceptibility tests became available, the patient record was again investigated for changes in the antibiotic regimen. Of 57 urine samples and 103 sputa, 27 and 85, respectively, were derived from patients with an infection of the urinary tract or respiratory tract. The results of the Gram stain confirmed the physician's suspicion 91% of the time for urinary tract infections and 81% of the time for pulmonary infections. In 67% of the patients with suspected lower respiratory tract infections and in 58% of patients with suspected urinary tract infections, the antibiotic treatment recommended on the basis of the results of the Gram stain differed significantly from the antibiotic treatment that the physician would have prescribed had a microscopic examination not been performed. The microbiologist's advice on antibiotic treatment was followed in 79% of the cases of respiratory tract infection and in 65% of the cases of urinary tract infection. The antibiotic treatment was adjusted to the final results of culture and antimicrobial susceptibility testing in 54% of the urinary tract infections and in 31% of the respiratory tract infections. The results indicate that the examination of sputa and urine in patients suspected to have an infection of the respiratory tract or urinary tract influences the antibiotic choice considerably.
Literature
1.
go back to reference Bartlett JG, Breiman RF, Mandell LM, File TM Jr (1998) Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 26:811–838PubMed Bartlett JG, Breiman RF, Mandell LM, File TM Jr (1998) Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 26:811–838PubMed
2.
go back to reference Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 31:347–382PubMed Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ (2000) Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 31:347–382PubMed
3.
go back to reference British Thoracic Society (2001) Guidelines for the management of community-acquired pneumonia in adults. Thorax 56 [Suppl 4]:1–64 British Thoracic Society (2001) Guidelines for the management of community-acquired pneumonia in adults. Thorax 56 [Suppl 4]:1–64
4.
go back to reference Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH (2000) Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. Can Respir J 7:371–382PubMed Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH (2000) Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. Can Respir J 7:371–382PubMed
5.
go back to reference Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754PubMed Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754PubMed
6.
7.
go back to reference Olson ML, Stanholtzer CJ, Willard KE, Peterson LR (1991) The slide centrifuge Gram stain as a urine screening method. Am J Clin Pathol 96:454–458PubMed Olson ML, Stanholtzer CJ, Willard KE, Peterson LR (1991) The slide centrifuge Gram stain as a urine screening method. Am J Clin Pathol 96:454–458PubMed
8.
go back to reference Morin S, Tretault J, James L, Hoppe-Bauer JE, Pezzlo M (1995) Specimen acceptability: evaluation of specimen quality. In: Isenberg HD (ed) Clinical microbiology procedures handbook. American Society for Microbiology, Washington DC, paragraph 1.3.1 Morin S, Tretault J, James L, Hoppe-Bauer JE, Pezzlo M (1995) Specimen acceptability: evaluation of specimen quality. In: Isenberg HD (ed) Clinical microbiology procedures handbook. American Society for Microbiology, Washington DC, paragraph 1.3.1
9.
go back to reference Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, Grayston JT, Wang SP, Kohler R, Muder RR, et al (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 69:307–316PubMed Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, Grayston JT, Wang SP, Kohler R, Muder RR, et al (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 69:307–316PubMed
10.
go back to reference Fine MJ, Orloff JJ, Rihs JD, Vickers RM, Kominos S, Kapoor WN, Arena VC,Yu VL (1991) Evaluation of housestaff physicians' preparation and interpretation of sputum Gram stains for community-acquired pneumonia. J Gen Med 6:189–198 Fine MJ, Orloff JJ, Rihs JD, Vickers RM, Kominos S, Kapoor WN, Arena VC,Yu VL (1991) Evaluation of housestaff physicians' preparation and interpretation of sputum Gram stains for community-acquired pneumonia. J Gen Med 6:189–198
11.
go back to reference Fine MJ, Stone RA, Singer DE, Coley CM, Marrie TJ, Lave JR, Hough LJ, Obrosky DS, Schulz R, Ricci EM, Rogers JC, Kapoor WN (1999) Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Reasearch Team (PORT) Cohort Study. Arch Intern Med 159:970–980PubMed Fine MJ, Stone RA, Singer DE, Coley CM, Marrie TJ, Lave JR, Hough LJ, Obrosky DS, Schulz R, Ricci EM, Rogers JC, Kapoor WN (1999) Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Reasearch Team (PORT) Cohort Study. Arch Intern Med 159:970–980PubMed
12.
go back to reference Levy M, Dromer F, Brion N, Leturdu F, Carbon C (1988) Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations. Chest 92:43–48 Levy M, Dromer F, Brion N, Leturdu F, Carbon C (1988) Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations. Chest 92:43–48
13.
go back to reference Marrie TJ, Durant H, Yates L (1989) Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 11:586–599PubMed Marrie TJ, Durant H, Yates L (1989) Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 11:586–599PubMed
14.
go back to reference Roson B, Carratala J, Verdaquer R, Dorca J, Manresa F, Gudiol F (2000) Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 31:869–874CrossRefPubMed Roson B, Carratala J, Verdaquer R, Dorca J, Manresa F, Gudiol F (2000) Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 31:869–874CrossRefPubMed
15.
go back to reference Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG (1987) Prospective study of the aetiology and outcome of pneumonia in the community. Lancet i:671–674 Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG (1987) Prospective study of the aetiology and outcome of pneumonia in the community. Lancet i:671–674
16.
go back to reference Boerner DF, Zwadyk P (1982) The value of the sputum Gram's stain in community-acquired pneumonia. JAMA 247:642–645PubMed Boerner DF, Zwadyk P (1982) The value of the sputum Gram's stain in community-acquired pneumonia. JAMA 247:642–645PubMed
17.
go back to reference Dans PE, Character P, Fahey M, Otter SE (1984) Management of pneumonia in the prospective payment era. Arch Intern Med 144:1392–1397PubMed Dans PE, Character P, Fahey M, Otter SE (1984) Management of pneumonia in the prospective payment era. Arch Intern Med 144:1392–1397PubMed
18.
go back to reference Gleckman R, DeVita J, Hibert D, Pelletier C, Martin R (1988) Sputum Gram stain assessment in community-acquired bacteremic pneumonia. J Clin Microbiol 26:846–849PubMed Gleckman R, DeVita J, Hibert D, Pelletier C, Martin R (1988) Sputum Gram stain assessment in community-acquired bacteremic pneumonia. J Clin Microbiol 26:846–849PubMed
19.
go back to reference Kalin M, Lindberg AA, Tunevall G (1983) Etiological diagnosis of bacterial pneumonia by Gram stain and quantitative culture of expectorates. Scand J Infect Dis 15:153–160PubMed Kalin M, Lindberg AA, Tunevall G (1983) Etiological diagnosis of bacterial pneumonia by Gram stain and quantitative culture of expectorates. Scand J Infect Dis 15:153–160PubMed
20.
go back to reference Perlino CA (1984) Laboratory diagnosis of pneumonia due to Streptococcus pneumoniae. J Infect Dis 150:139–144PubMed Perlino CA (1984) Laboratory diagnosis of pneumonia due to Streptococcus pneumoniae. J Infect Dis 150:139–144PubMed
21.
go back to reference Rein MF, Gwaltney JM, O'Brien WM, Jennings RH, Mandell GL (1978) Accuracy of Gram's stain in identifying pneumococci in sputum. JAMA 239:2671–2673PubMed Rein MF, Gwaltney JM, O'Brien WM, Jennings RH, Mandell GL (1978) Accuracy of Gram's stain in identifying pneumococci in sputum. JAMA 239:2671–2673PubMed
22.
go back to reference Sadeghi E, Matlow A, MacLusky I, Karmali MA (1994) Utility of Gram stain in evaluation of sputa from patients with cystic fibrosis. J Clin Microbiol 32:54–58PubMed Sadeghi E, Matlow A, MacLusky I, Karmali MA (1994) Utility of Gram stain in evaluation of sputa from patients with cystic fibrosis. J Clin Microbiol 32:54–58PubMed
23.
go back to reference Barrett-Connor E (1971) The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Respir Dis 103:845–848PubMed Barrett-Connor E (1971) The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Respir Dis 103:845–848PubMed
24.
go back to reference Heineman HS, Chawla JK, Lofton WM (1977) Misinformation from sputum cultures without microscopic examination. J Clin Microbiol 6:518–527PubMed Heineman HS, Chawla JK, Lofton WM (1977) Misinformation from sputum cultures without microscopic examination. J Clin Microbiol 6:518–527PubMed
25.
go back to reference Lepow ML, Balassanian N, Emmerich J, Roberts RB, Rosenthal MS, Wolinksky E (1968) Interrelationships of viral, mycoplasmal, and bacterial agents in uncomplicated pneumonia. Am Rev Respir Dis 97:533–545PubMed Lepow ML, Balassanian N, Emmerich J, Roberts RB, Rosenthal MS, Wolinksky E (1968) Interrelationships of viral, mycoplasmal, and bacterial agents in uncomplicated pneumonia. Am Rev Respir Dis 97:533–545PubMed
26.
go back to reference Bartlett JG, Mundy LM (1995) Current concepts: community-acquired pneumonia. N Engl J Med 333:1618–1624 Bartlett JG, Mundy LM (1995) Current concepts: community-acquired pneumonia. N Engl J Med 333:1618–1624
27.
go back to reference Kalin A, Lindberg AA (1983) Diagnosis of pneumococcal pneumonia: a comparison between microscopic examination of expectorate, antigen detection and cultural procedures. Scand J Infect Dis 15:247–255PubMed Kalin A, Lindberg AA (1983) Diagnosis of pneumococcal pneumonia: a comparison between microscopic examination of expectorate, antigen detection and cultural procedures. Scand J Infect Dis 15:247–255PubMed
28.
go back to reference La Force FM (1985) Community-acquired lower respiratory tract infections. Prevention and cost-control strategies. Am J Med 78 [Suppl 6B]:52–57 La Force FM (1985) Community-acquired lower respiratory tract infections. Prevention and cost-control strategies. Am J Med 78 [Suppl 6B]:52–57
29.
go back to reference Marrie TJ (1994) Community-acquired pneumonia. Clin Infect Dis 18:501–515PubMed Marrie TJ (1994) Community-acquired pneumonia. Clin Infect Dis 18:501–515PubMed
30.
go back to reference Pomilla PV, Brown RB (1994) Outpatient treatment of community-acquired pneumonia in adults. Arch Intern Med 154:1793–1802PubMed Pomilla PV, Brown RB (1994) Outpatient treatment of community-acquired pneumonia in adults. Arch Intern Med 154:1793–1802PubMed
31.
go back to reference Hayden FG, Osterhaus ADME, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K (1997) Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. N Engl J Med 337:874–880PubMed Hayden FG, Osterhaus ADME, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K (1997) Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. N Engl J Med 337:874–880PubMed
Metadata
Title
Usefulness of Gram Stain for Diagnosis of Lower Respiratory Tract Infection or Urinary Tract Infection and as an Aid in Guiding Treatment
Authors
E. J. Kuijper
J. van der Meer
M. D. de Jong
P. Speelman
J. Dankert
Publication date
01-04-2003
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2003
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-003-0892-8

Other articles of this Issue 4/2003

European Journal of Clinical Microbiology & Infectious Diseases 4/2003 Go to the issue

Announcements

April 2003

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.